News Overview

Park Basel Area Home to Top European Accelerator Baselaunch

Author: Switzerland Innovation Park Basel Area
On the left: Stephan Emmerth, Director Therapeutic Innovation and BaseLaunch
On the left: Stephan Emmerth, Director Therapeutic Innovation and BaseLaunch

The Switzerland Innovation Park Basel Area in Allschwil is not only home to biotech startups but also hosts one of Europe’s top accelerators: Healthcare Accelerator BaseLaunch, which is operated by the location promotion organization, is one of the leading accelerators of its kind in Europe, according to a report on the news platform “Sifted”. BaseLaunch is the only Swiss Healthcare Accelerator to feature.

“Sifted”, an online magazine supported by the “Financial Times”, has analyzed the leading Healthcare Accelerators in Europe. It aimed to find out which accelerators provide healthcare startups with the best opportunities for development and to find investment. According to the article, BaseLaunch is the rarest type of accelerator – it provides investment and support without asking for equity in return. Instead, big industry funding comes from companies like Novartis, Roche, Roivant Sciences, Johnson & Johnson, Pfizer and KPMG.

Basel is already world-famous in life sciences, but BaseLaunch is supporting even more startups making exciting developments. It offers them business development and legal services, as well as fully equipped labs at the Switzerland Innovation Park Basel Area. Furthermore, grants are available up to 250,000 Swiss francs per company by the end of the 15-month programme. BaseLaunch supports companies innovating in therapeutics, medtech and diagnostics.

Among the companies that were selected to take part in the accelerator are T3 Pharmaceuticals, Polyneuron, Alentis or Anaveon. In 2019 alone, BaseLaunch startups were able to raise 70 million Swiss francs, with Polyneuron raising 22.5 million, Alentis 12.5 million and Anaveon 35 million Swiss francs.